BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Update

BioNexus Gene Lab Corp. (NASDAQ:BGLC) saw a significant increase in short interest in May. As of May 15th, there was short interest totalling 63,600 shares, an increase of 25.7% from the April 30th total of 50,600 shares. Currently, 5.4% of the shares of the stock are sold short. Based on an average daily volume of 618,600 shares, the days-to-cover ratio is currently 0.1 days.

BioNexus Gene Lab Price Performance

BioNexus Gene Lab stock opened at $3.70 on Tuesday. The business’s fifty day moving average is $2.82 and its two-hundred day moving average is $3.11. BioNexus Gene Lab has a 52 week low of $2.01 and a 52 week high of $8.40.

BioNexus Gene Lab (NASDAQ:BGLC) last posted its quarterly earnings data on Thursday, May 15th. The company reported ($0.03) EPS for the quarter. BioNexus Gene Lab had a negative return on equity of 9.93% and a negative net margin of 10.17%.

Wall Street Analyst Weigh In

Separately, Wall Street Zen lowered BioNexus Gene Lab to a “strong sell” rating in a research note on Friday.

BioNexus Gene Lab Company Profile

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.